Awarded
Anifrolumab 300 mg in 2 ml Konzentrat Infusionslösungskonzentrat St
- Buyer
- PBMG eG
- Winners
- ASTRAZENECA GMBH
- Contract value
- no value published
- Bids received
- 1
- Published
- 2 Mar 2026
- Awarded
- 30 Dec 2025
- Contract start
- 1 Jul 2026
- Contract end
- 30 Jun 2027stated
- Region
- Hamburg (DE600)